ReleaseWire

Stocks Trending Alert: Incyte Corporation (NASDAQ:INCY), Tower Group International, Ltd.(NASDAQ:TWGP), Sarepta Therapeutics Inc (NASDAQ:SRPT), Tripadvisor Inc (NASDAQ:TRIP)

Posted: Monday, August 12, 2013 at 9:21 AM CDT

Lewes, DE -- (SBWire) -- 08/12/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Incyte Corporation (NASDAQ:INCY), Tower Group International, Ltd.(NASDAQ:TWGP), Sarepta Therapeutics Inc (NASDAQ:SRPT), Tripadvisor Inc (NASDAQ:TRIP)

Incyte Corporation (NASDAQ:INCY) opened its shares at the price of $26.64 for the day. Its closing price was $27.29 after gaining +1.98% for the day. The company traded with the total volume of 1.47 million shares, while its average trading volume remained 1.14 million shares. The beta of INCY stands at2.15.

Incyte Corporation (Incyte) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat serious unmet medical needs.

Why Should Investors Buy INCY After The Recent Gain? Just Go Here and Find Out

Tower Group International, Ltd.(NASDAQ:TWGP) percentage change plunged -1.16% to close at $16.22 with the total traded volume of 1.45 million shares, and average volume of 522,253.00 shares. The 52 week range of the stock remained $16.19 - $22.30, while its day lowest price was $16.19 and it hit its day highest price at $16.80.

Has TWGP Found The Bottom and Ready To Move Up? Find Out Here

Sarepta Therapeutics Inc (NASDAQ:SRPT) started its trading session with the price of $36.64 and closed at $34.94 by scoring -5.18%. SRPT’s stocks traded with total volume of 1.45 million shares, while the average trading volume remained 1.89 million shares. The beta of SRPT stands at 1.22. Day range of the stock was $34.85 -$36.89.

Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases.\

Has SRPT Found The Bottom And Ready To Gain Momentum? Find Out Here

Tripadvisor Inc (NASDAQ:TRIP) ended its day with the gain of +1.54% and closed at the price of $80.94 after opening at $80.90. Stock traded during its last trading session with the total volume of 1.43 million shares, as compared to its average volume of 1.80 million shares.

TripAdvisor, Inc. (TripAdvisor) is an online travel research company, enabling users to plan and have a trip. TripAdvisor features reviews and advice on hotels, resorts, flights, vacation rentals, vacation packages and travel guides.

Will TRIP Continue To Move Higher? Find Out Here

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/